You are here

Emgality

Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec

Eli Lilly, under pressure from Biohaven, launches head-to-head migraine trial between Emgality and Nurtec

Fierce Pharma

clinical trials

Flag link:

As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth

As Lilly gears up for key 2022 launches, Trulicity, Taltz and more drive solid growth

Fierce Pharma

Flag link:

Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug

Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug

BioSpace

Teva Pharmaceutical

Flag link:

Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio

Lilly warms up for Olympics with Team USA athletes in ads for Trulicity, Emgality and Verzenio

Fierce Pharma

pharma marketing

Flag link:

Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study

Eli Lilly pins injectable migraine med Emgality against Biohaven's oral rival Nurtec ODT in head-to-head study

Fierce Pharma

Flag link:

Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'

Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'

Fierce Pharma

Teva Pharmaceutical

Flag link:

Lilly launches real-world study to benchmark Emgality against migraine rivals

Lilly launches real-world study to benchmark Emgality against migraine rivals

Fierce Pharma

real world evidence

Flag link:

Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share

Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share

Fierce Pharma

Flag link:

Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study

Racing after the leaders, Eli Lilly's migraine drug clears another pivotal study

Endpoints

clinical trials

chronic migraine

episodic migraine

Flag link:

Lilly's Emgality powers ahead with 'best-in-class' CGRP access

Lilly's Emgality powers ahead with 'best-in-class' CGRP access

Fierce Pharma

Teva Pharmaceutical

Flag link:

Emgality-maker Lilly courts payers with new migraine ER data

Emgality-maker Lilly courts payers with new migraine ER data

Fierce Pharma

cluster headache

Teva Pharmaceutical

Flag link:

Lilly enlists patients to raise cluster headache awareness after Emgality scores second nod

Lilly enlists patients to raise cluster headache awareness after Emgality scores second nod

Fierce Pharma

cluster headaches

Flag link:

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

Eli Lilly Takes Aim at Chronic Pain Problem, Alleviating Opiate Addiction

TheStreet.com

cluster headaches

Flag link:

Lilly's scored its cluster headache nod for Emgality. Will it shake up the CGRP race?

Lilly's scored its cluster headache nod for Emgality. Will it shake up the CGRP race?

Fierce Pharma

cluster headaches

Flag link:

How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says

How can Teva's migraine drug face off Amgen and Lilly? Put neurologists first, DTC last, executive says

Fierce Pharma

Teva Pharmaceutical

DTC advertising

Flag link:

Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

Lilly's new migraine drug pulls ahead of Amgen in fierce battle for new prescriptions

Yahoo/Reuters

Teva Pharmaceutical

Flag link:

Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine

Eli Lilly's Emgality shows positive Phase 3 results in treatment of migraine

Pharmafile

clinical trials

Flag link:

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

Xconomy

Teva Pharmaceutical

Flag link:

Faint hope for Alder as Teva bucks dismal migraine trend

Faint hope for Alder as Teva bucks dismal migraine trend

EP Vantage

Alder Biopharmaceuticals

Flag link:

Lilly claims fast FDA review for Emgality in cluster headache

Lilly claims fast FDA review for Emgality in cluster headache

Pharmaforum

episodic cluster headache

Flag link:

Pages